Behind-The-Counter Drug Class “On The Table” At CHPA
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association appears to have softened its steadfast opposition to a possible behind-the-counter third class of drugs
You may also be interested in...
CHPA on third class of drugs
Two-class system of Rx and OTC drug regulation is a "time-tested system that provides consumers with convenient, cost-effective and safe treatment options," trade group maintains in 1May 27 statement reaffirming its opposition to "third class, or so-called transition class" of drugs. 2"The Tan Sheet" May 26, 2003 (p. 5) suggested CHPA was re-assessing its long-standing opposition to the idea of a third class...
CHPA on third class of drugs
Two-class system of Rx and OTC drug regulation is a "time-tested system that provides consumers with convenient, cost-effective and safe treatment options," trade group maintains in 1May 27 statement reaffirming its opposition to "third class, or so-called transition class" of drugs. 2"The Tan Sheet" May 26, 2003 (p. 5) suggested CHPA was re-assessing its long-standing opposition to the idea of a third class...
CHPA on third class of drugs
Two-class system of Rx and OTC drug regulation is a "time-tested system that provides consumers with convenient, cost-effective and safe treatment options," trade group maintains in 1May 27 statement reaffirming its opposition to "third class, or so-called transition class" of drugs. 2"The Tan Sheet" May 26, 2003 (p. 5) suggested CHPA was re-assessing its long-standing opposition to the idea of a third class...